抗菌药物耐药领导力小组实验室中心:整合传统与创新方法引领抗菌实验室研究
抗菌药物耐药领导力小组(ARLG)实验室中心(LC)通过科学领导与标准化/专业化实验室服务,推动基于实验室的研究评估、开发与实施。LC建立了实体与虚拟菌株库,并与诊断公司及MASTERMIND计划协作评估快速分子诊断,同时与统计数据中心合作开发整合微生物与遗传数据的耐药分析策略。
要点
- ARLG LC建立实体和虚拟菌株库,提供菌株及科学指导支持研究与开发。
- LC与MASTERMIND计划协作,用纯化菌株评估快速分子诊断设备。
- LC与SDMC合作开发整合微生物与遗传数据的耐药识别新分析策略。
核心结论
- ARLG实验室中心通过整合传统与创新方法,在菌株资源、诊断评估和耐药分析方面取得多项成果。
研究设计与样本
- 本文为实验室中心工作介绍,总结其建立的实体和虚拟菌株库、实验室研究及合作项目。
主要发现
- 实体菌株库保存ARLG资助研究的细菌分离株,虚拟菌株目录包含已表征的革兰阳性和阴性菌株。
- LC与诊断公司及MASTERMIND计划协作,用纯化菌株评估快速分子诊断设备。
- LC与SDMC合作开发整合微生物与遗传数据的新分析策略,以更准确识别抗菌药物耐药。
临床怎么用
- ARLG菌株及科学技术指导可提供给基础研究实验室和诊断公司用于研发。
- 菌株申请需经LC与领导运营中心制定的审查批准程序及选择指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Antibacterial Resistance Leadership Group (ARLG) Laboratory Center (LC) leads the evaluation, development, and implementation of laboratory-based research by providing scientific leadership and supporting standard/specialized laboratory services. The LC has developed a physical biorepository and a virtual biorepository. The physical biorepository contains bacterial isolates from ARLG-funded studies located in a centralized laboratory and they are available to ARLG investigators. The Web-based virtual biorepository strain catalogue includes well-characterized gram-positive and gram-negative bacterial strains published by ARLG investigators. The LC, in collaboration with the ARLG Leadership and Operations Center, developed procedures for review and approval of strain requests, guidance during the selection process, and for shipping strains from the distributing laboratories to the requesting investigators. ARLG strains and scientific and/or technical guidance have been provided to basic research laboratories and diagnostic companies for research and development, facilitating collaboration between diagnostic companies and the ARLG Master Protocol for Evaluating Multiple Infection Diagnostics (MASTERMIND) initiative for evaluation of multiple diagnostic devices from a single patient sampling event. In addition, the LC has completed several laboratory-based studies designed to help evaluate new rapid molecular diagnostics by developing, testing, and applying a MASTERMIND approach using purified bacterial strains. In collaboration with the ARLG's Statistical and Data Management Center (SDMC), the LC has developed novel analytical strategies that integrate microbiologic and genetic data for improved and accurate identification of antimicrobial resistance. These novel approaches will aid in the design of future ARLG studies and help correlate pathogenic markers with clinical outcomes. The LC's accomplishments are the result of a successful collaboration with the ARLG's Leadership and Operations Center, Diagnostics and Devices Committee, and SDMC. This interactive approach has been pivotal for the success of LC projects.
引用
- Manca C, Hill C, Hujer AM, et al. Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2017. PMID: 28350898. doi:10.1093/cid/ciw826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。